FDA.reportPublic FDA data

Fintepla 2.2 MG/ML Oral Solution

RxCUI
2381144
RxNorm name
Fintepla 2.2 MG/ML Oral Solution
Display name
Fintepla 2.2 MG/ML Oral Solution
Full name
Fintepla 2.2 MG/ML Oral Solution
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:26

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
e88f360e-33ad-4cd6-b2de-5ef885857c5dFintepla 2.2 MG/mL Oral Solution [PSN] · fenfluramine 2.2 MG/ML Oral Solution [Fintepla] [SBD] · fenfluramine 2.2 MG/ML (as fenfluramine HCl 2.5 MG/ML) Oral Solution [Fintepla] [SY] · Fintepla 2.2 MG/ML Oral Solution [SY]416These highlights do not include all the information needed to use FINTEPLA safely and effectively. See full prescribing information for FINTEPLA. FINTEPLA ® (fenfluramine) oral solution Initial U.S. Approval: 197320251027